Phosphorylation of p300 increases its protein degradation to enhance the lung cancer progression

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 6, 2014, Pages 1135-1149

  Wang, Shao An ^a   Hung, Chia Yang ^b   Chuang, Jian Ying ^c   Chang, Wen Chang ^a,b,d   Hsu, Tsung I ^a   Hung, Jan Jong ^a,b,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

CDK1; Metastasis; Mitosis; P300; Phosphorylation; Protein stability

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE 1; E1A ASSOCIATED P300 PROTEIN; GELATINASE B; HISTONE H3; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; NERVE CELL ADHESION MOLECULE; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; METASTASIS; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; S PHASE CELL CYCLE CHECKPOINT;

CDK1; METASTASIS; MITOSIS; P300; PHOSPHORYLATION; PROTEIN STABILITY;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CDC2 PROTEIN KINASE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; E1A-ASSOCIATED P300 PROTEIN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; MITOSIS; NEOPLASM INVASIVENESS; PROTEOLYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; UTEROGLOBIN; WOUND HEALING;

EID: 84896053095     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.02.001     Document Type: Article

References (70)

1. Luo R.X., Dean D.C. Chromatin remodeling and transcriptional regulation. J. Natl. Cancer Inst. 1999, 91:1288-1294.
2. Cheung W.L., Briggs S.D., Allis C.D. Acetylation and chromosomal functions. Curr. Opin. Cell Biol. 2000, 12:326-333.
3. Kuo M.H., Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 1998, 20:615-626.
4. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
5. Sawan C., Herceg Z. Histone modifications and cancer. Adv. Genet. 2010, 70:57-85.
6. Selvi R.B., Kundu T.K. Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics. Biotechnol. J. 2009, 4:375-390.
7. Giles R.H., Peters D.J., Breuning M.H. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 1998, 14:178-183.
8. Giordano A., Avantaggiati M.L. p300 and CBP: partners for life and death. J. Cell. Physiol. 1999, 181:218-230.
9. Goodman R.H., Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 2000, 14:1553-1577.
10. Chan H.M., La Thangue N.B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 2001, 114:2363-2373.
11. Suske G. The Sp-family of transcription factors. Gene 1999, 238:291-300.
12. Snowden A.W., Perkins N.D. Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protein. Biochem. Pharmacol. 1998, 55:1947-1954.
13. Moran E. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 1993, 3:63-70.
14. Karamouzis M.V., Konstantinopoulos P.A., Papavassiliou A.G. Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis. Cell Res. 2007, 17:324-332.
15. Iyer N.G., Ozdag H., Caldas C. p300/CBP and cancer. Oncogene 2004, 23:4225-4231.
16. Turnell A.S., Mymryk J.S. Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation. Br. J. Cancer 2006, 95:555-560.
17. Muench P., Probst S., Schuetz J., Leiprecht N., Busch M., Wesselborg S., Stubenrauch F., Iftner T. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. Cancer Res. 2010, 70:6913-6924.
18. Kim W.J., Lee J.W., Quan C., Youn H.J., Kim H.M., Bae S.C. Nicotinamide inhibits growth of carcinogen induced mouse bladder tumor and human bladder tumor xenograft through up-regulation of RUNX3 and p300. J. Urol. 2011, 185:2366-2375.
19. Yokomizo C., Yamaguchi K., Itoh Y., Nishimura T., Umemura A., Minami M., Yasui K., Mitsuyoshi H., Fujii H., Tochiki N., Nakajima T., Okanoue T., Yoshikawa T. High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells. Cancer Lett. 2011, 310:140-147.
20. Santer F.R., Hoschele P.P., Oh S.J., Erb H.H., Bouchal J., Cavarretta I.T., Parson W., Meyers D.J., Cole P.A., Culig Z. Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines. Mol. Cancer Ther. 2011, 10:1644-1655.
21. Heemers H.V., Sebo T.J., Debes J.D., Regan K.M., Raclaw K.A., Murphy L.M., Hobisch A., Culig Z., Tindall D.J. Androgen deprivation increases p300 expression in prostate cancer cells. Cancer Res. 2007, 67:3422-3430.
22. Ishihama K., Yamakawa M., Semba S., Takeda H., Kawata S., Kimura S., Kimura W. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas. J. Clin. Pathol. 2007, 60:1205-1210.
23. Phillips A.C., Vousden K.H. Acetyltransferases and tumour suppression. Breast Cancer Res. 2000, 2:244-246.
24. Gayther S.A., Batley S.J., Linger L., Bannister A., Thorpe K., Chin S.F., Daigo Y., Russell P., Wilson A., Sowter H.M., Delhanty J.D., Ponder B.A., Kouzarides T., Caldas C. Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 2000, 24:300-303.
25. Shikama N., Lee C.W., France S., Delavaine L., Lyon J., Krstic-Demonacos M., La Thangue N.B. A novel cofactor for p300 that regulates the p53 response. Mol. Cell 1999, 4:365-376.
26. Grossman S.R. p300/CBP/p53 interaction and regulation of the p53 response. Eur. J. Biochem. 2001, 268:2773-2778.
27. Yuan Z.M., Huang Y., Ishiko T., Nakada S., Utsugisawa T., Shioya H., Utsugisawa Y., Yokoyama K., Weichselbaum R., Shi Y., Kufe D. Role for p300 in stabilization of p53 in the response to DNA damage. J. Biol. Chem. 1999, 274:1883-1886.
28. Strebhardt K. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat. Rev. Drug Discov. 2010, 9:643-660.
29. Yuan L.W., Soh J.W., Weinstein I.B. Inhibition of histone acetyltransferase function of p300 by PKCdelta. Biochim. Biophys. Acta 2002, 1592:205-211.
30. Chen J., Halappanavar S.S., St-Germain J.R., Tsang B.K., Li Q. Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. Cell. Mol. Life Sci. 2004, 61:1675-1683.
31. Liu Y., Denlinger C.E., Rundall B.K., Smith P.W., Jones D.R. Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. J. Biol. Chem. 2006, 281:31359-31368.
32. Chen Y.J., Wang Y.N., Chang W.C. ERK2-mediated C-terminal serine phosphorylation of p300 is vital to the regulation of epidermal growth factor-induced keratin 16 gene expression. J. Biol. Chem. 2007, 282:27215-27228.
33. Bricambert J., Miranda J., Benhamed F., Girard J., Postic C., Dentin R. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J. Clin. Invest. 2010, 120:4316-4331.
34. Huang W.C., Chen C.C. Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol. Cell. Biol. 2005, 25:6592-6602.
35. Poizat C., Puri P.L., Bai Y., Kedes L. Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. Mol. Cell. Biol. 2005, 25:2673-2687.
36. Wang Q.E., Han C., Zhao R., Wani G., Zhu Q., Gong L., Battu A., Racoma I., Sharma N., Wani A.A. p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair. Nucleic Acids Res. 2013, 41:1722-1733.
37. Jang E.R., Choi J.D., Jeong G., Lee J.S. Phosphorylation of p300 by ATM controls the stability of NBS1. Biochem. Biophys. Res. Commun. 2010, 397:637-643.
38. Jang E.R., Choi J.D., Lee J.S. Acetyltransferase p300 regulates NBS1-mediated DNA damage response. FEBS Lett. 2011, 585:47-52.
39. Chu Y.W., Yang P.C., Yang S.C., Shyu Y.C., Hendrix M.J., Wu R., Wu C.W. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol. 1997, 17:353-360.
40. Chuang J.Y., Wang Y.T., Yeh S.H., Liu Y.W., Chang W.C., Hung J.J. Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. Mol. Biol. Cell 2008, 19:1139-1151.
41. Banerjee A.C., Recupero A.J., Mal A., Piotrkowski A.M., Wang D.M., Harter M.L. The adenovirus E1A 289R and 243R proteins inhibit the phosphorylation of p300. Oncogene 1994, 9:1733-1737.
42. Wang S.A., Li H.Y., Hsu T.I., Chen S.H., Wu C.J., Chang W.C., Hung J.J. Heat shock protein 90 stabilizes nucleolin to increase mRNA stability in mitosis. J. Biol. Chem. 2011, 286:43816-43829.
43. Moreno S., Nurse P. Substrates for p34cdc2: in vivo veritas?. Cell 1990, 61:549-551.
44. Shima Y., Shima T., Chiba T., Irimura T., Pandolfi P.P., Kitabayashi I. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol. Cell. Biol. 2008, 28:7126-7138.
45. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 64:435-459.
46. Hsu T.I., Wang M.C., Chen S.Y., Yeh Y.M., Su W.C., Chang W.C., Hung J.J. Sp1 expression regulates lung tumor progression. Oncogene 2012, 31:3973-3988.
47. Zhao X., Benveniste E.N. Transcriptional activation of human matrix metalloproteinase-9 gene expression by multiple co-activators. J. Mol. Biol. 2008, 383:945-956.
48. Pacheco-Pinedo E.C., Durham A.C., Stewart K.M., Goss A.M., Lu M.M., Demayo F.J., Morrisey E.E. Wnt/beta-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. J. Clin. Invest. 2011, 121:1935-1945.
49. Tran P.T., Fan A.C., Bendapudi P.K., Koh S., Komatsubara K., Chen J., Horng G., Bellovin D.I., Giuriato S., Wang C.S., Whitsett J.A., Felsher D.W. Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas. PLoS One 2008, 3:e2125.
50. Chen J., Li Q. Life and death of transcriptional co-activator p300. Epigenetics 2011, 6:957-961.
51. Jain S., Wei J., Mitrani L.R., Bishopric N.H. Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival. Breast Cancer Res. Treat. 2012, 135:103-114.
52. Gautier J., Minshull J., Lohka M., Glotzer M., Hunt T., Maller J.L. Cyclin is a component of maturation-promoting factor from Xenopus. Cell 1990, 60:487-494.
53. Wasner M., Tschop K., Spiesbach K., Haugwitz U., Johne C., Mossner J., Mantovani R., Engeland K. Cyclin B1 transcription is enhanced by the p300 coactivator and regulated during the cell cycle by a CHR-dependent repression mechanism. FEBS Lett. 2003, 536:66-70.
54. Zeestraten E.C., Maak M., Shibayama M., Schuster T., Nitsche U., Matsushima T., Nakayama S., Gohda K., Friess H., van de Velde C.J., Ishihara H., Rosenberg R., Kuppen P.J., Janssen K.P. Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer. Br. J. Cancer 2012, 106:133-140.
55. Liu P., Kao T.P., Huang H. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene 2008, 27:4733-4744.
56. Payton M., Chung G., Yakowec P., Wong A., Powers D., Xiong L., Zhang N., Leal J., Bush T.L., Santora V., Askew B., Tasker A., Radinsky R., Kendall R., Coats S. Discovery and evaluation of dual CDK1 and CDK2 inhibitors. Cancer Res. 2006, 66:4299-4308.
57. Eckner R., Ewen M.E., Newsome D., Gerdes M., DeCaprio J.A., Lawrence J.B., Livingston D.M. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 1994, 8:869-884.
58. Bannister A.J., Kouzarides T. CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 1995, 14:4758-4762.
59. Bannister A.J., Oehler T., Wilhelm D., Angel P., Kouzarides T. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 1995, 11:2509-2514.
60. Avantaggiati M.L., Ogryzko V., Gardner K., Giordano A., Levine A.S., Kelly K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 1997, 89:1175-1184.
61. Lill N.L., Grossman S.R., Ginsberg D., DeCaprio J., Livingston D.M. Binding and modulation of p53 by p300/CBP coactivators. Nature 1997, 387:823-827.
62. Pouponnot C., Jayaraman L., Massague J. Physical and functional interaction of SMADs and p300/CBP. J. Biol. Chem. 1998, 273:22865-22868.
63. Patel D., Huang S.M., Baglia L.A., McCance D.J. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 1999, 18:5061-5072.
64. Ghosh A.K., Yuan W., Mori Y., Varga J. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000, 19:3546-3555.
65. Martinez-Balbas M.A., Bauer U.M., Nielsen S.J., Brehm A., Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J. 2000, 19:662-671.
66. Marzio G., Wagener C., Gutierrez M.I., Cartwright P., Helin K., Giacca M. E2F family members are differentially regulated by reversible acetylation. J. Biol. Chem. 2000, 275:10887-10892.
67. Pao G.M., Janknecht R., Ruffner H., Hunter T., Verma I.M. CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1020-1025.
68. Tomita A., Towatari M., Tsuzuki S., Hayakawa F., Kosugi H., Tamai K., Miyazaki T., Kinoshita T., Saito H. c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300. Oncogene 2000, 19:444-451.
69. Sankar N., Kadeppagari R.K., Thimmapaya B. c-Myc-induced aberrant DNA synthesis and activation of DNA damage response in p300 knockdown cells. J. Biol. Chem. 2009, 284:15193-15205.
70. Vervoorts J., Luscher-Firzlaff J.M., Rottmann S., Lilischkis R., Walsemann G., Dohmann K., Austen M., Luscher B. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 2003, 4:484-490.